DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tdsvp7/opioid_addiction) has announced the addition of the "Opioid Addiction Pipeline Highlights - 2014 Update" report to their offering.
The latest report Opioid Addiction Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Opioid Addiction market. It covers emerging therapies for Opioid Addiction in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Opioid Addiction pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Opioid Addiction pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Opioid Addiction pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which Opioid Addiction pipeline products will be launched in the US and Ex-US till 2017.
Key Topics Covered:
1. Opioid Addiction Pipeline by Stages
2. Opioid Addiction Pipeline by Drug Class
3. Opioid Addiction Pipeline by Company
4. Opioid Addiction Phase 3 Clinical Trial Insights
5. Opioid Addiction Phase 2 Clinical Trial Insights
6. Opioid Addiction Phase 1 Clinical Trial Insights
7. Opioid Addiction Preclinical Research Insights
8. Opioid Addiction Discovery Stage Insights
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/tdsvp7/opioid_addiction